Utama › Kanser Ginjal (Karsinoma Sel Renal) › Wilayah Columbia › Washington
Kajian klinikal Kanser Ginjal (Karsinoma Sel Renal) di Washington, DC
13 kajian untuk Kanser Ginjal (Karsinoma Sel Renal) sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
Mengambil pesertaFasa 2
- NCI - Center for Cancer Research, Bethesda · 7 mi jauh
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Mengambil pesertaFasa 1/2
- Sibley Memorial Hospital, Washington D.C.
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
Mengambil pesertaFasa 2
- Georgetown University, Washington D.C.
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Mengambil pesertaFasa 3
- MedStar Washington Hospital Center, Washington D.C.
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Mengambil pesertaFasa 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Mengambil pesertaFasa 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
Mengambil pesertaFasa 2
- Sibley Memorial Hospital, Washington D.C.
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Mengambil pesertaFasa 3
- MedStar Washington Hospital Center, Washington D.C.
Kajian Kanser Ginjal (Karsinoma Sel Renal) di bandar lain
- Houston, TX35 kajian
- New York City, NY27 kajian
- Nashville, TN23 kajian
- Dallas, TX23 kajian
- St. Louis, MO23 kajian
- Los Angeles, CA20 kajian
- Boston, MA16 kajian
- Baldwin Park, CA16 kajian
- Philadelphia, PA15 kajian
- Pittsburgh, PA15 kajian
- Queens, NY15 kajian
- Rochester, MN14 kajian
Kajian lain di Washington
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil55 kajian
- Kanser Payudara46 kajian
- Kanser Metastatik43 kajian
- Kanser Paru-paru41 kajian
- Kanser Prostat38 kajian
- Obesiti33 kajian
- Kanser Kolorektal29 kajian
- Penyakit Kardiovaskular28 kajian
- Kanser Pundi Kencing26 kajian
- Leukemia Mieloid Akut24 kajian
- Kanser Ovari23 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.